Know which studies, sites, vendors, and programs need attention.
Clinical development leaders need an operating picture across studies, not a set of disconnected updates. Vivo gives leaders a shared view of trial progress, risk, and performance before issues escalate.
Where teams get stuck today.
Portfolio reviews depend on manually assembled updates from each study team
Risk escalation arrives after issues have already matured into timeline or quality problems
No consistent view of cross-study patterns in sites, vendors, data quality, or enrollment
Milestone risk and resource allocation decisions are made from stale, fragmented information
Preparing executive reporting requires hours of reconciliation across sources
What Vivo makes possible.
Portfolio-level visibility into trial status, risk, performance, enrollment, and milestone pressure
Cross-study risk patterns: sites, vendors, data quality trends recurring across programs
Portfolio Ask Vivo — ask questions across studies and receive source-backed answers
Executive reporting: what-changed summaries, risk snapshots, and milestone views
Resource prioritization: surface where leadership attention will have the most impact
Drill from portfolio view → study → site → subject → evidence in one platform
The questions Portfolio Leadership teams ask Vivo every day.
Which studies have the highest execution risk this month?
Which sites or vendors are creating risk across multiple trials?
What changed across the portfolio since the last review?
Which studies are at risk of milestone slippage?
Where should leadership focus attention this week?
We reached database lock early, even against our stretch goal. That's never happened in my career.
See risk, performance, and priorities across studies.
See how Vivo helps clinical development leaders with live trial data, source-backed AI, and governed action workflows.
